Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance

Neurocrine Biosciences (NBIX) Tops Q2 EPS by 44c

August 1, 2023 7:06 AM EDT

Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $1.25, $0.44 better than the analyst estimate of $0.81. Revenue for the quarter came in at $452.7 million versus the consensus estimate of $446.75 million.

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

... More